Chong Kun Dang Pharmaceutical Corp. (KRX:185750)

Market Cap	1.09T
Revenue (ttm)	1.63T
Net Income (ttm)	95.28B
Shares Out	13.18M
EPS (ttm)	7,211.37
PE Ratio	11.51
Forward PE	15.33
Dividend	1,100.00 (1.33%)
Ex-Dividend Date	Dec 27, 2024

Volume	36,814
Average Volume	69,753
Open	83,000
Previous Close	82,700
Day's Range	82,600 - 84,000
52-Week Range	70,900 - 124,000
Beta	0.70
RSI	47.49
Earnings Date	Jul 25, 2025

About Silk Road Medical

Chong Kun Dang Pharmaceutical Corp. engages in the manufacturing, marketing, and sales of medicines in South Korea and internationally. It provides prescription drugs for anticancer, anti-hypertension, anti-hyperlipidemia, anti-diabetic, and immunosuppressant products; over-the-counter drugs for therapeutic benefits, supplements, and other preventive products; health supplements with preventive benefits, including prebiotics and vitamins with Omega-3; and consumer health products, such as red-ginseng healthy drink, hand sanitizer, and hair colo...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1941
• Employees: 2,281
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 185750

Financial Performance

In 2024, KRX:185750's revenue was 1.59 trillion, a decrease of -4.97% compared to the previous year's 1.67 trillion. Earnings were 109.07 billion, a decrease of -48.68%.